Dergiler / Haydarpaşa Numune Medical Journal / 2022 / Cilt: 62 - Sayı: 1

Evaluation of Perinatal Outcomes in Intrahepatic Cholestasis of Pregnancy

Sayfa
82–86
Yayın Tarihi
2022-10-19
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Therefore, early diagnosis and active management are essential in reducing adverse complications related to ICP.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Introduction: This study aimed to retrospectively evaluate the perinatal outcomes of the cases followed up in our clinic for Intrahepatic cholestasis of pregnancy (ICP).
📊
Temel Bulgular & Veri:Methods: In this study, the medical records of 71 patients who applied to Sakarya University Training and Research Hospital, Gynecology and Obstetrics Clinic between April 2015 and March 2021 and were diagnosed with ICP were analyzed retrospectively.
💡
Sonuç & Katkı:Therefore, early diagnosis and active management are essential in reducing adverse complications related to ICP.
🔬Tür:Araştırma Makalesi
📍Kapsam:2015 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Introduction: This study aimed to retrospectively evaluate the perinatal outcomes of the cases followed up in our clinic for Intrahepatic cholestasis of pregnancy (ICP). Methods: In this study, the medical records of 71 patients who applied to Sakarya University Training and Research Hospital, Gynecology and Obstetrics Clinic between April 2015 and March 2021 and were diagnosed with ICP were analyzed retrospectively. Results: The mean age of the patients was 28.9±4.8 years. At the time of diagnosis, the mean week of gestation was 31.9±2.4 weeks, and the mean week of gestation at birth was 36.7±1.5 weeks. It was determined that 20 (28.2%) of the patients had preterm birth before 37 weeks of gestation. The gestational week at the time of diagnosis was found to be statistically significantly lower in patients who had preterm birth (30.5±1.7) compared to those who did not (32±2.5) who did not have preterm birth (p:0.025). When the correlation analysis was performed, a statistically significant negative correlation was found between the gestational week at the time of diagnosis and preterm birth (p=0.024, r=−0.268). Discussion and Conclusion: Although ICP is a benign condition for the mother, it can cause significant complications in the fetus. Therefore, early diagnosis and active management are essential in reducing adverse complications related to ICP.

🔖

Bu Makaleye Atıf Yap

ÖZDEN, S., GÖK, K., BOSTANCI, M. S., ÖZGÜL, A., YILMAZ, E., GÖK, N. R. (2022). Evaluation of Perinatal Outcomes in Intrahepatic Cholestasis of Pregnancy. Haydarpaşa Numune Medical Journal, Cilt: 62 - Sayı: 1, 82–86. https://ajindex.com/articles/535842

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Dixon PH, Williamson C. The pathophysiology of intrahepatic cholestasis of pregnancy. Clin Res Hepatol Gastroenterol 2016;40:141–53
  2. Shao Y, Chen J, Zheng J, Liu CR. Effect of histone deacetylase HDAC3 on cytokines IL-18, IL-12 and TNF-α in patients with intrahepatic cholestasis of pregnancy. Cell Physiol Biochem 2017;42:1294–302
  3. Clinical updates in women's health care summary: Liver disease: Reproductive considerations. Obstet Gynecol 2017;129:236
  4. Wikström Shemer E, Marschall HU, Ludvigsson JF, Stephansson O. Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: A 12-year populationbased cohort study. BJOG 2013;120:717–23
  5. Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol 2009;15:2049–66
  6. Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA. Liver disease in pregnancy. Lancet 2010;375:594–605
  7. Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Ilio C, Chambers J, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: Results of aggregate and individual patient data meta-analyses. Lancet 2019;393:899–909
  8. Labbe C, Delesalle C, Creveuil C, Dreyfus M. Cholestases intrahepatiques gravidiques (CIG) précoces et tardives: étude des complications materno-foetales [Early and later intrahepatic cholestasis of pregnancy (ICP): Study of adverse pregnancy outcomes]. Gynecol Obstet Fertil Senol 2018;46:388–94. [Article in French] 9. Yang J, Chen C, Liu M, Zhang S. Women successfully treated for severe intrahepatic cholestasis of pregnancy do not have increased risks for adverse perinatal outcomes. Medicine (Baltimore) 2019;98:e16214
  9. Geenes VL, Lim YH, Bowman N, Tailor H, Dixon PH, Chambers J, et al. A placental phenotype for intrahepatic cholestasis of pregnancy. Placenta 2011;32:1026–32
  10. Ibrahim E, Diakonov I, Arunthavarajah D, Swift T, Goodwin M, McIlvride S, et al. Bile acids and their respective conjugates elicit different responses in neonatal cardiomyocytes: Role of Gi protein, muscarinic receptors and TGR5. Sci Rep 2018;8:7110
  11. Güven D, Altunkaynak BZ, Altun G, Alkan I, Kocak I. Histomorphometric changes in the placenta and umbilical cord during complications of pregnancy. Biotech Histochem 2018;93:198– 210
  12. Cui D, Zhong Y, Zhang L, Du H. Bile acid levels and risk of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy: A meta-analysis. J Obstet Gynaecol Res 2017;43:1411–20. 1